Although not assessed in a formal manner, he reported appetite suppression and achieved a weight loss of 15 kg (122 kg, BMI 48.9 kg/m 2 , WC of 134 cm, WHR 0.97) over the first eight months of treatment and maintained during the next three months
Table 2 also shows the changes in eGFR and annual eGFR decline depending on the preceding drug in the unadjusted model
At every checkpoint, 3 months, 6 months, 9 months, and 12 months, women on combination therapy showed a higher percentage of total body weight loss
Whether youre looking for a diabetes medicine for weight loss or exploring cutting-edge treatments, this class of drugs offers exciting possibilities for the future of healthcare
Nor does it explain another surprising finding from the study: men taking these weight-loss treatments appeared to face three times the risk of vision loss compared to women